SciNeuro Pharmaceuticals

SciNeuro Pharmaceuticals

This company develops neurological medicines and drug delivery platforms for patients with central nervous system diseases, including Alzheimer's and dementia.

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Asceneuron

The company develops oral small molecule therapies for neurodegenerative diseases including Alzheimer's and Parkinson's to treat patients suffering from chronic neurologic disorders.

Rapport Therapeutics

This company develops small molecule precision medicines for patients suffering from central nervous system disorders.

CoSyne Therapeutics

The company develops artificial intelligence platforms to discover precision medicines for patients with brain cancer and neurological conditions.

Cerevance

This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.